Worldwide Is Poised to Take Your Sjogren’s Syndrome Research Study to the Next Level

Sjogren’s syndrome is an autoimmune disorder typically characterized by exocrine dysfunction, resulting in dry eyes and dry mouth. Often accompanying other conditions such as rheumatoid arthritis or lupus, Sjogren’s syndrome has the potential to affect vital organ function. Current therapies treat symptoms, and no disease-modifying therapies have proven effective through randomized placebo-controlled trials.

From its earliest days in dementia-related research, Worldwide Clinical Trials has built its reputation by staying at the forefront of medical research. With IMID as one of our core focuses, our scientific and medical professionals seek to understand the conditions underlying presenting symptoms in order to gain a fuller understanding of IMID conditions and develop therapies to target them. With our long history of clinical trial research and an in-depth understanding of regulatory trends, our trial design strategies optimize your chances for success.

From Phase I-IV through real-world evidence studies, trust the experts at Worldwide Clinical Trials.